VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML. - Kretschmer, Lydia; Ruhnke, Leo; Schliemann, Christoph; Fransecky, Lars; Steffen, Björn; Kaufmann, Martin; Burchert, Andreas; Schmid, Christoph; Hanoun, Maher; Sauer, Tim; Metzeler, Klaus H.; Schäfer-Eckart, Kerstin; et al. (Annals of Hematology, 2025)